RESEARCH HIGHLIGHTS

Researchers at Heinrich Heine University and Forschungszentrum Jülich are using high-performance computing in tandem with experimental research to better understand a common, antibiotic-resistant infection prevalent in healthcare settings.

Using high-performance computing at HLRS, researchers ran large-scale molecular dynamics simulations to investigate hard-to-treat genetic mutations linked to aggressive cancers.

The mRNA vaccine for COVID-19 was the first of its kind, demonstrating the potential of a new biomedical paradigm. Computational research at the Johannes Gutenberg University Mainz could open new opportunities for mRNA-based medicines.

Using a combination of CT-scans, other available patient data, and simulations, researchers are forging a path toward personalizing medicine and improving outcomes for patients with acute respiratory illnesses. In collaboration with the Leibniz Supercomputing Centre, researchers from the Technical University of Munich are developing new computational methods to put insights from more accurate modelling and simulation into the hands of medical professionals.

High-performance computing provides essential tools for drug discovery and epidemiological modeling in the fight against the global pandemic.